Institutional Ownership Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). We have compiled data on the 487 institutions that hold shares in the stock, with a total of 64.1 Million shares, which have been reported (via 13F filing form) to have a value of $2.79 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
Feb 04, 2025 Q4 2024 |
8,973,064
shares
|
$393 Million
3.09% of portfolio
|
Q4 2024
Added 19.66%
|
|
|
Capital International Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
8,743,523
shares
|
$383 Million
0.07% of portfolio
|
Q4 2024
Added 10.3%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,811,708
shares
|
$167 Million
0.09% of portfolio
|
Q4 2024
Added 39.24%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,777,784
shares
|
$122 Million
0.0% of portfolio
|
Q2 2024
Added 9.09%
|
|
|
Nikko Asset Management Americas, Inc.
|
Feb 10, 2025 Q4 2024 |
2,745,676
shares
|
$120 Million
1.21% of portfolio
|
Q4 2024
Reduced 7.47%
|
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Jan 28, 2025 Q4 2024 |
2,745,676
shares
|
$120 Million
0.07% of portfolio
|
Q4 2024
Reduced 7.49%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,491,525
shares
|
$109 Million
0.0% of portfolio
|
Q4 2024
Reduced 16.75%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,983,990
shares
|
$87 Million
0.01% of portfolio
|
Q4 2024
Added 194.54%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
1,735,998
shares
|
$76.1 Million
0.0% of portfolio
|
Q4 2024
Added 0.61%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
1,587,854
shares
|
$69.6 Million
4.46% of portfolio
|
Q4 2022
Reduced 0.14%
|
|
|
Orbis Allan Gray LTD
Hamilton, D0 |
Feb 14, 2025 Q4 2024 |
1,476,119
shares
|
$64.7 Million
0.39% of portfolio
|
Q4 2024
New holding
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,389,276
shares
|
$60.9 Million
2.55% of portfolio
|
Q1 2024
New holding
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,308,011
shares
|
$57.3 Million
0.57% of portfolio
|
Q4 2024
Added 55.15%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
1,211,509
shares
|
$53.1 Million
0.0% of portfolio
|
Q4 2024
Added 11.99%
|
|
|
Sr One Capital Management, LP
|
Feb 13, 2025 Q4 2024 |
1,048,951
shares
|
$46 Million
15.37% of portfolio
|
Q1 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,000,868
shares
|
$43.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.73%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
947,301
shares
|
$41.5 Million
0.01% of portfolio
|
Q4 2024
Added 14.88%
|
|
|
Loomis Sayles & CO L P
|
Feb 12, 2025 Q4 2024 |
910,965
shares
|
$39.9 Million
0.05% of portfolio
|
Q4 2024
Reduced 3.63%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
893,935
shares
|
$39.2 Million
0.06% of portfolio
|
Q4 2024
Added 43.34%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
878,896
shares
|
$38.5 Million
0.01% of portfolio
|
Q4 2024
Added 69.49%
|
|
|
Contrarius Investment Management LTD
St. Helier, Y9 |
Nov 08, 2024 Q3 2024 |
783,898
shares
|
$34.4 Million
2.1% of portfolio
|
Q3 2024
Added 14.32%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
723,032
shares
|
$31.7 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.17%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
719,309
shares
|
$31.5 Million
0.05% of portfolio
|
Q1 2024
Reduced 17.9%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
690,191
shares
|
$30.3 Million
0.01% of portfolio
|
Q4 2024
Added 2.05%
|
|
|
Versant Venture Management, LLC
San Francisco, CA |
Feb 11, 2025 Q4 2024 |
498,558
shares
|
$21.9 Million
29.01% of portfolio
|
Q3 2021
Reduced 1.97%
|